Literature DB >> 19033487

Comment: Clinical pharmaceutics and calcium ceftriaxone.

Marko Puzovic, Gil Hardy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033487     DOI: 10.1345/aph.1K410b

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  2 in total

1.  Impact of the FDA warning of potential ceftriaxone and calcium interactions on drug use policy in clinical practice.

Authors:  John S Esterly; Emily Steadman; Marc H Scheetz
Journal:  Int J Clin Pharm       Date:  2011-03-29

2.  Evaluation of a potential clinical interaction between ceftriaxone and calcium.

Authors:  Emily Steadman; Dennis W Raisch; Charles L Bennett; John S Esterly; Tischa Becker; Michael Postelnick; June M McKoy; Steve Trifilio; Paul R Yarnold; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.